Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Boston Scientific details strategic objectives at investor meeting

Boston Scientific details strategic objectives at investor meeting

8th May 2015

Boston Scientific has provided details of its current business strategy and growth objectives during its 2015 investor day.

During the event in New York, the company confirmed that it is targeting at or above-market operational revenue growth and consistent double-digit adjusted earnings growth in 2015, based on positive results from 2014 and the first quarter of this year.

It holds the number one or number two position in five out of its seven business areas, with momentum within its cardiovascular, rhythm management and MedSurg divisions set to be driven by new product launches, as well as the planned acquisition of the American Medical Systems urology portfolio.

Additionally, Boston Scientific will be diversifying its portfolio away from 60 percent in slower growth markets in 2012 to 40 percent by 2019, while increasing its penetration in emerging markets.

Mike Mahoney, president and chief executive officer of Boston Scientific, said: "We are focused on addressing the unmet needs of patients, physicians and healthcare systems through differentiated technologies and comprehensive portfolios within the market categories where we have deep expertise."ADNFCR-8000103-ID-801786723-ADNFCR

We currently have 10 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.